重组人白介素-2（IL-2）

重组人白介素-2（IL-2）[PRP1025] - 人源无标签细胞因子

产品概述

本产品为大肠杆菌表达的重组人源IL-2蛋白，通过Ala21-Thr153序列片段（UniProt ID: P60568-1）实现精准表达，采用无标签纯化工艺，适用于细胞培养及相关研究应用。

技术参数

• 分子量：15.5 KDa（理论值）｜16 KDa（SDS-PAGE还原条件）
• 纯度：＞98%（SDS-PAGE验证）
• 生物活性：ED₅₀=2.269 ng/ml（CTLL-2细胞增殖实验）
• 内毒素：＜1.0 EU/μg（LAL法检测）
• 制剂形式：冻干粉（20 mM Tris，50 mM NaCl，pH 5.0，含1 mM DTT及EDTA）

产品规格与价格

规格	价格（RMB）	货期
10 μg	588	现货
50 μg	1,498	现货
100 μg	1,716	现货
1 mg	8,016	咨询

使用指南

• 复溶建议：使用配套复溶缓冲液（≥100 μg/mL），后续实验按需稀释
• 离心要求：开盖前需离心处理
• 稳定性：复溶后4℃保存≤7天，长期保存需添加0.1% HSA/BSA，-20℃分装

保存与运输

• 储存条件：冻干粉≤-20℃干燥保存
• 运输方式：蓝冰低温运输

重要声明

研究用途产品，不适用于人类或临床诊断。产品应用须符合当地法规要求，使用前请充分验证实验方案可行性。

```

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

Recombinant Human Interleukin-2 (IL-2) [PRP1025] - Tag-free Human Cytokine

Product Overview

This product is a E. coli-expressed recombinant human IL-2 protein, precisely expressed using the Ala21-Thr153 sequence fragment (UniProt ID: P60568-1). It is purified via a tag-free process and suitable for cell culture and related research applications.

Technical Specifications

• Molecular Weight: 15.5 KDa (Theoretical) | 16 KDa (SDS-PAGE under reducing conditions)
• Purity: >98% (SDS-PAGE verified)
• Biological Activity: ED<sub>50</sub>=2.269 ng/ml (CTLL-2 cell proliferation assay)
• Endotoxin: <1.0 EU/μg (LAL assay)
• Formulation: Lyophilized powder (20 mM Tris, 50 mM NaCl, pH 5.0, containing 1 mM DTT and EDTA)

Product Specifications & Pricing

Specification	Price (RMB)	Lead Time
10 μg	588	In stock
50 μg	1,498	In stock
100 μg	1,716	In stock
1 mg	8,016	Inquire

Usage Guidelines

• Reconstitution: Use provided reconstitution buffer (≥100 μg/mL), dilute as needed for subsequent experiments
• Centrifugation: Centrifuge before opening
• Stability: Reconstituted product stable at 4℃ for ≤7 days; for long-term storage, add 0.1% HSA/BSA and aliquot at -20℃

Storage & Shipping

• Storage Conditions: Lyophilized powder should be stored dry at ≤-20℃
• Shipping Method: Shipped on blue ice

Important Notice

For research use only, not intended for human or clinical diagnostics. Product applications must comply with local regulations. Validate experimental feasibility prior to use.

Note: The above information may be subject to change due to product optimization and upgrades. For specific details, please consult AcroBiosystems.